Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -5.40 (-3.93%)
Bid:
131.40
Ask:
132.40
Spread: 1.00 (0.761%)
Market Cap: £321.31m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

4 Dec 2023 07:00

RNS Number : 4801V
PureTech Health PLC
04 December 2023
Ā 

04 December 2023

Ā 

PureTech Health plc

Ā 

Transaction in Own Shares

Ā 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Ā 

Date of purchase:

01 December 2023

Number of ordinary shares purchased:

37,605

Highest price paid per share:

154.00p

Lowest price paid per share:

148.20p

Volume weighted average price paid per share:

150.74p

Ā 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,789,229 ordinary shares in treasury and has 272,678,930 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 272,678,930 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

Ā 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

Ā 

About PureTech Health

PureTechĀ is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities.Ā PureTech'sĀ R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (PlenityĀ® and EndeavorRxĀ®) that have received bothĀ U.S. FDAĀ clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced byĀ PureTechĀ or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by theĀ PureTechĀ team through key validation points.

Ā 

For more information, visitĀ www.puretechhealth.comĀ or connect with us on X, formerly known as Twitter, @puretechh.

Ā 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

Ā 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

01/12/2023

08:07:02

627

154

XLON

00380596261TRLO0.1.1

01/12/2023

08:11:12

627

153

CHIX

00380598886TRLO0.1.1

01/12/2023

08:36:35

127

149.8

AQXE

00380610612TRLO0.1.1

01/12/2023

08:36:35

627

150.2

XLON

00380610614TRLO0.1.1

01/12/2023

08:36:35

627

150.2

XLON

00380610613TRLO0.1.1

01/12/2023

08:36:40

344

148.2

BATE

00380610620TRLO0.1.1

01/12/2023

08:36:40

97

149

TRQX

00380610621TRLO0.1.1

01/12/2023

10:01:47

929

149.4

XLON

00380628665TRLO0.1.1

01/12/2023

10:01:47

952

149.4

XLON

00380628666TRLO0.1.1

01/12/2023

10:01:49

33

148.6

AQXE

00380628677TRLO0.1.1

01/12/2023

10:01:49

344

148.6

BATE

00380628678TRLO0.1.1

01/12/2023

10:01:49

627

148.6

CHIX

00380628679TRLO0.1.1

01/12/2023

10:01:49

94

148.6

AQXE

00380628681TRLO0.1.1

01/12/2023

10:01:49

97

148.6

TRQX

00380628680TRLO0.1.1

01/12/2023

10:01:49

16

148.6

AQXE

00380628682TRLO0.1.1

01/12/2023

10:01:49

12

148.6

AQXE

00380628683TRLO0.1.1

01/12/2023

10:06:12

220

148.4

XLON

00380629131TRLO0.1.1

01/12/2023

10:45:12

252

149.4

XLON

00380633099TRLO0.1.1

01/12/2023

10:56:04

1254

149

XLON

00380634511TRLO0.1.1

01/12/2023

13:20:48

190

150

CHIX

00380651428TRLO0.1.1

01/12/2023

13:20:48

142

150

BATE

00380651429TRLO0.1.1

01/12/2023

13:21:22

437

150

CHIX

00380651502TRLO0.1.1

01/12/2023

13:21:22

202

150

BATE

00380651504TRLO0.1.1

01/12/2023

13:21:22

627

150

CHIX

00380651503TRLO0.1.1

01/12/2023

13:21:22

127

150

AQXE

00380651506TRLO0.1.1

01/12/2023

13:21:22

115

150

BATE

00380651505TRLO0.1.1

01/12/2023

13:21:22

285

150

BATE

00380651508TRLO0.1.1

01/12/2023

13:21:22

127

150

AQXE

00380651507TRLO0.1.1

01/12/2023

13:21:22

155

150

XLON

00380651510TRLO0.1.1

01/12/2023

13:21:22

86

150

BATE

00380651509TRLO0.1.1

01/12/2023

13:21:22

730

150

XLON

00380651511TRLO0.1.1

01/12/2023

13:21:22

360

150

XLON

00380651512TRLO0.1.1

01/12/2023

13:21:22

9

150

XLON

00380651513TRLO0.1.1

01/12/2023

13:21:23

97

149.6

TRQX

00380651515TRLO0.1.1

01/12/2023

13:21:23

97

149.6

TRQX

00380651516TRLO0.1.1

01/12/2023

14:00:40

261

150.2

XLON

00380659538TRLO0.1.1

01/12/2023

14:28:02

344

149.4

BATE

00380664849TRLO0.1.1

01/12/2023

14:28:02

344

149.4

BATE

00380664850TRLO0.1.1

01/12/2023

14:28:02

627

149.2

CHIX

00380664851TRLO0.1.1

01/12/2023

14:28:02

1254

149.4

XLON

00380664852TRLO0.1.1

01/12/2023

14:28:02

97

148.6

TRQX

00380664853TRLO0.1.1

01/12/2023

14:28:02

97

148.6

TRQX

00380664854TRLO0.1.1

01/12/2023

14:28:08

12

149.4

CHIX

00380664931TRLO0.1.1

01/12/2023

14:46:15

495

152

XLON

00380676698TRLO0.1.1

01/12/2023

14:46:15

187

152

XLON

00380676699TRLO0.1.1

01/12/2023

16:01:23

627

152

CHIX

00380703933TRLO0.1.1

01/12/2023

16:01:23

15

152

XLON

00380703934TRLO0.1.1

01/12/2023

16:01:23

1866

152

XLON

00380703935TRLO0.1.1

01/12/2023

16:01:25

127

151.8

AQXE

00380703941TRLO0.1.1

01/12/2023

16:02:30

627

151.2

CHIX

00380704355TRLO0.1.1

01/12/2023

16:02:30

1881

151.2

XLON

00380704356TRLO0.1.1

01/12/2023

16:02:30

172

151.2

BATE

00380704357TRLO0.1.1

01/12/2023

16:04:06

1314

151.2

XLON

00380704917TRLO0.1.1

01/12/2023

16:04:06

204

151.2

XLON

00380704918TRLO0.1.1

01/12/2023

16:04:09

636

151.2

CHIX

00380704942TRLO0.1.1

01/12/2023

16:04:10

1313

151.2

XLON

00380704951TRLO0.1.1

01/12/2023

16:04:10

186

151.2

XLON

00380704952TRLO0.1.1

01/12/2023

16:04:17

314

151.2

XLON

00380704985TRLO0.1.1

01/12/2023

16:04:17

203

151.2

XLON

00380704986TRLO0.1.1

01/12/2023

16:04:24

1314

151.2

XLON

00380705071TRLO0.1.1

01/12/2023

16:04:28

949

151.2

XLON

00380705088TRLO0.1.1

01/12/2023

16:04:28

298

151.2

XLON

00380705089TRLO0.1.1

01/12/2023

16:04:35

459

151.2

XLON

00380705124TRLO0.1.1

01/12/2023

16:04:35

244

151.2

XLON

00380705125TRLO0.1.1

01/12/2023

16:04:36

37

151.2

BATE

00380705126TRLO0.1.1

01/12/2023

16:04:36

50

151.2

BATE

00380705128TRLO0.1.1

01/12/2023

16:04:43

170

151.2

XLON

00380705177TRLO0.1.1

01/12/2023

16:08:47

168

151.4

XLON

00380707261TRLO0.1.1

01/12/2023

16:08:54

349

152

CHIX

00380707311TRLO0.1.1

01/12/2023

16:11:01

2

151.8

BATE

00380708054TRLO0.1.1

01/12/2023

16:11:01

105

151.6

CHIX

00380708055TRLO0.1.1

01/12/2023

16:11:01

1

151.6

CHIX

00380708056TRLO0.1.1

01/12/2023

16:11:01

14

151.6

CHIX

00380708058TRLO0.1.1

01/12/2023

16:11:01

979

151.6

CHIX

00380708057TRLO0.1.1

01/12/2023

16:11:35

1

151.6

CHIX

00380708319TRLO0.1.1

01/12/2023

16:12:47

522

151.4

CHIX

00380708926TRLO0.1.1

01/12/2023

16:12:48

157

151.4

XLON

00380708930TRLO0.1.1

01/12/2023

16:12:48

22

151.4

XLON

00380708931TRLO0.1.1

01/12/2023

16:17:18

172

152

BATE

00380710681TRLO0.1.1

01/12/2023

16:17:18

237

151.4

XLON

00380710682TRLO0.1.1

01/12/2023

16:17:45

2

152

BATE

00380710812TRLO0.1.1

01/12/2023

16:18:40

2

152

BATE

00380711082TRLO0.1.1

01/12/2023

16:19:37

2

152

BATE

00380711467TRLO0.1.1

01/12/2023

16:20:06

264

151.4

CHIX

00380711622TRLO0.1.1

01/12/2023

16:20:10

127

151.4

AQXE

00380711632TRLO0.1.1

01/12/2023

16:20:10

51

151.4

BATE

00380711633TRLO0.1.1

01/12/2023

16:20:10

94

151.4

BATE

00380711634TRLO0.1.1

01/12/2023

16:20:39

98

151.4

CHIX

00380711800TRLO0.1.1

01/12/2023

16:23:56

576

151.2

XLON

00380712887TRLO0.1.1

01/12/2023

16:23:56

627

151.2

XLON

00380712886TRLO0.1.1

01/12/2023

16:23:56

226

151

XLON

00380712889TRLO0.1.1

01/12/2023

16:23:56

254

151

XLON

00380712888TRLO0.1.1

01/12/2023

16:23:56

52

151

TRQX

00380712891TRLO0.1.1

01/12/2023

16:23:56

45

151

TRQX

00380712890TRLO0.1.1

01/12/2023

16:23:56

172

151.2

BATE

00380712906TRLO0.1.1

01/12/2023

16:23:56

13

151.2

BATE

00380712907TRLO0.1.1

01/12/2023

16:25:33

1316

151.2

XLON

00380713400TRLO0.1.1

01/12/2023

16:25:33

787

151.2

XLON

00380713402TRLO0.1.1

01/12/2023

16:25:33

240

151.2

XLON

00380713401TRLO0.1.1

01/12/2023

16:25:41

2

151.2

BATE

00380713496TRLO0.1.1

01/12/2023

16:28:20

124

150.6

XLON

00380714239TRLO0.1.1

01/12/2023

16:28:34

127

150.6

AQXE

00380714297TRLO0.1.1

01/12/2023

16:28:34

465

150.6

BATE

00380714298TRLO0.1.1

01/12/2023

16:28:34

503

150.6

XLON

00380714299TRLO0.1.1

01/12/2023

16:29:49

16

151.2

TRQX

00380714852TRLO0.1.1

01/12/2023

16:29:49

275

151.2

TRQX

00380714853TRLO0.1.1

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
POSFFFSVFLLFIIV
12345678910
Date   Source Headline
10th Jun 20265:38 pmRNSResult of AGM
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
PHAR
Pharos Energy
LSE
0.00%
RST
Restore
LSE
2.06%
LAM
LAM.L
LSE
0.00%
FOUR
4Imprint
LSE
2.12%
HGG
HGG.L
LSE
0.00%
Trending
FORG
Forgent
LSE
17.86%
GST
GSTechnologies
LSE
13.33%
FCM
First Class Metals PLC
LSE
-20.73%
KEFI
Kefi Gold & Copper
LSE
-1.90%
GGP
Greatland Resources
LSE
-1.64%